Baku 9° C
BioNTech, Pfizer studying new COVID variant
Health
- 26 November, 2021
- 13:30
BioNTech and Pfizer said that experts are studying a new variant of coronavirus discovered in South Africa, more information is expected in two weeks, Report informs.
“We expect more laboratory data in two weeks at the latest,” BioNTech spokesman said, according to Agence France-Presse.
The company stressed that the data will help to understand whether the variant of coronavirus B.1.1.529 could “require a vaccine adjustment” by Pfizer/BioNTech in the event that it spreads worldwide.
Author
Latest News
18:14
Hezbollah says it targeted Israeli military base
Other countries18:02
Turkish president, UK PM discuss recent developments in Middle East
Region17:53
Ilham Aliyev grateful to Albanian President for his resolute stance
Foreign policy17:45
Bayramov, Saidov mull regional developments on sidelines of OTS ministerial meeting
Foreign policy17:38
Heavy rains and flooding kills at least 23 in Nairobi
Other countries17:25
Türkiye considering deployment of F-16s to Northern Cyprus
Region17:19
Jeyhun Bayramov mulls Iranian drone attacks on Azerbaijan's Nakhchivan with OTS Sec.-Gen.
Foreign policy17:04
MFA: About 1,000 Azerbaijani citizens applied for evacuation from Middle East
Domestic policy16:45